American International Group, Inc. Checkpoint Therapeutics, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.36 - $3.2 $71,189 - $96,528	-30,165 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$2.6 - $4.16 $210 - $336	81 Added 0.27%	30,165 $95,000
Q4 2020 Feb 12, 2021	BUY	$2.19 - $2.96 $6,839 - $9,244	3,123 Added 11.58%	30,084 $80,000
Q3 2020 Nov 04, 2020	BUY	$1.62 - $4.24 $3,202 - $8,382	1,977 Added 7.91%	26,961 $72,000
Q2 2020 Aug 12, 2020	BUY	$1.19 - $2.27 $4,915 - $9,377	4,131 Added 19.81%	24,984 $49,000
Q1 2020 May 04, 2020	BUY	$1.11 - $2.43 $6,140 - $13,442	5,532 Added 36.11%	20,853 $31,000
Q4 2019 Feb 05, 2020	SELL	$1.18 - $2.39 $152 - $308	-129 Reduced 0.83%	15,321 $26,000
Q3 2019 Nov 08, 2019	BUY	$2.15 - $3.36 $1,702 - $2,661	792 Added 5.4%	15,450 $38,000
Q2 2019 Aug 13, 2019	BUY	$2.75 - $5.0 $40,309 - $73,290	14,658 New	14,658 $45,000

1.91M

Ticker CKPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,497,000
Market Cap $304M
Description
Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.